indazoles has been researched along with abt-737 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, WJ; He, QJ; Lin, NM; Wu, HH; Yang, B; Yang, W; Zhang, C; Zheng, L; Zhu, H | 1 |
| Andreeff, M; Benito, J; Ciurea, SO; Jin, L; Kojima, K; Konopleva, M; McQueen, T; Miida, T; Ruvolo, V; Shikami, M; Tabe, Y; Wang, RY | 1 |
| Basaga, H; Gul, O; Karakas, B; Kutuk, O; Ozmay, Y | 1 |
3 other study(ies) available for indazoles and abt-737
| Article | Year |
|---|---|
GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Caspases; Cell Line, Tumor; Drug Synergism; Female; Humans; Indazoles; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Transplantation; Nitrophenols; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides | 2011 |
PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment.
Topics: Apoptosis; Biphenyl Compounds; Bone Marrow; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Drug Synergism; Gene Expression Regulation, Leukemic; Humans; Hypoxia; Indazoles; Leukemia, Myeloid, Acute; Mesenchymal Stem Cells; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Phosphoinositide-3 Kinase Inhibitors; Piperazines; RNA Interference; Sulfonamides; Tumor Microenvironment | 2013 |
Distinct apoptotic blocks mediate resistance to panHER inhibitors in HER2+ breast cancer cells.
Topics: bcl-X Protein; Benzothiazoles; Biphenyl Compounds; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Isoquinolines; Nitrophenols; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolinones; Quinolines; Receptor, ErbB-2; Sulfonamides | 2018 |